Stereotaxis Inc
AMEX:STXS
Relative Value
The Relative Value of one STXS stock under the Base Case scenario is hidden USD. Compared to the current market price of 2.18 USD, Stereotaxis Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
STXS Competitors Multiples
Stereotaxis Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
S
|
Stereotaxis Inc
AMEX:STXS
|
187.5m USD | 5.9 | -7.6 | -7.9 | -7.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
189.2B USD | 4.3 | 29.1 | 16.5 | 22.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172B USD | 17 | 60 | 45.7 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
137.5B USD | 5.5 | 42.5 | 21.6 | 26.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
135.6B USD | 7 | 48.7 | 28.5 | 38.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
133.3B USD | 3.8 | 27.8 | 15.5 | 22.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
58.7B USD | 2.7 | 35.1 | 12.9 | 21.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.6B EUR | 2 | 22.2 | 12.6 | 17.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51B USD | 12 | 48.9 | 35.2 | 38.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.8B USD | 8.1 | 34.9 | 24.8 | 27.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.7B USD | 6.8 | 24.7 | 17.4 | 19.4 |